In our breast cancer study we found ankyrin 3 expression levels to be up-regulated compared to normal tissue, while here we report ankyrin 3 levels to be down-regulated (approximately 1.6 fold) [expression values 350.02 vs. 224.48], in BCC compared to normal tissue. This evidence concerns the gene ANK3 and breast carcinoma.